Poly(ADP-ribose) Polymerase Inhibitors
- Poly(ADP-ribose) Polymerase Inhibitors
- Accession Number
Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.
Drug Drug Description Olaparib A chemotherapeutic agent used to treat recurrent or advanced ovarian cancer and metastatic breast cancer in patients with specific mutations and prior history of chemotherapy. Niraparib A poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. Rucaparib An anti-cancer agent used to treat recurrent ovarian, fallopian tube, or peritoneal cancer. 3-Methoxybenzamide Not Available 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide Not Available Veliparib Not Available Talazoparib A poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer. Iniparib Not Annotated
- Drugs & Drug Targets